Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases

NCT00026494 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer

Interventions

DRUG: temozolomide
DRUG: vinorelbine tartrate

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]